Paul J. Bernard
Besancon, 25000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
First Sustainable One-Pot Tandem Hantzsch Multicomponent Reaction/Click Reaction Approach for Novel Multitarget-Directed Ligands in Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: December 29, 2025
Confinement-driven state transition and bistability in schooling fish.
Journal: Physical review. E
Published: January 08, 2024
Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties.
Journal: Pharmaceutics
Published: December 01, 2023
Calcium channel blockers' contribution to overcoming Current drug discovery challenges in Alzheimer's disease.
Journal: Expert opinion on drug discovery
Published: October 06, 2023
Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment.
Journal: International journal of molecular sciences
Published: April 03, 2023
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation.
Journal: Molecules (Basel, Switzerland)
Published: November 27, 2022
Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties.
Journal: Molecules (Basel, Switzerland)
Published: September 30, 2022
Latest progress in the development of multitarget ligands for Alzheimer's disease based on the Hantzsch reaction.
Journal: Future medicinal chemistry
Published: May 24, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026